Advent France Biotechnology (AFB) and Invivo Ventures have invested in a €4.25m round for Spanish life sciences company Arthex Biotech, which develops RNA therapies for the treatment of myotonic dystrophy.
Exit from Main Fund V comes three years after the GP acquired the Germany-based procurement technology company
Unquote’s selection of the latest add-ons, with ICG's Circet, Five Arrows' Mintec, Carlyle's Jagex, and more
Lucie Cawood's appointment follows poaching of Ian Shawyer by Cleary Gottlieb earlier this month
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons